Mesenchymal Stem Cells Modulate Breast Cancer Progression through Their Secretome by Downregulating Ten-Eleven Translocation 1

Scientists investigated the role of MSC-derived secretome in modulating breast cancer cell behavior, with a focus on ten-eleven translocation 1 (TET1), a DNA demethylase with known oncogenic properties in triple-negative breast cancer.